Where is 3ive Labs located?

3ive Labs is headquartered in Roswell, United States.

How many employees does 3ive Labs have?

As of Jul 31, 2026, the latest employee count at 3ive Labs is 7.

Where does 3ive Labs rank among its competitors?

3ive Labs ranks 9th amongst 7 active competitors, only 1 of which is funded. Lowell Therapeutics, which secured $1M in Nov, 2021.

Who are the top competitors of 3ive Labs?

3ive Labs' top competitors include Sentien Biotechnologies, GE Global Research and NorrDia AB. Among them, Lowell Therapeutics secured the most recent funding round in November, 2021.

3ive Labs - 2026 Company Profile & Competitors

Company Details

Developer of devices to restore kidney function. The product JuxtaFlow system is for the treatment of elevated venous pressure and blood flow that causes acute decompensated heart failure and acute kidney injury. Another product NPD-2119 for restoration of renal function and treatment of chronic kidney disorder.

Website: 3ivelabs.com
Email ID: *****@3ivelabs.com

Key Metrics

Founded Year

2018

Location

Roswell, United States

Stage

Unfunded

Ranked

9^th among 12 competitors

Employee Count

7 as on Jul 31, 2026

Similar Companies

Sentien Biotechnologies & 10 more

View 3ive Labs' full profile

3ive Labs has not raised any funding rounds yet.

3ive Labs' employee count trend

3ive Labs has 7 employees as of Jul 26. Here is 3ive Labs's employee count trend over the years:

Uncover 3ive Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of 3ive Labs include Sentien Biotechnologies, GE Global Research and NorrDia AB. Here is the list of Top 10 competitors of 3ive Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sentien Biotechnologies 2008, Lexington (United States), Series A	Developer of stem cell based device product for acute organ failure	$13M	Boehringer Ingelheim Venture Fund, Mission BioCapital ... & 6 others	45/100
2nd	GE Global Research 1900, China, Funding Raised	Developer of renal bio-replacement therapy for compromised kidney function treatment	-	-	36/100
3rd	NorrDia AB Unfunded	Developer of medical devices for the treatment of renal care	-	-	32/100
4th	RenalGuard Solutions 1981, Milford (United States), Late Stage	Innovating AKI prevention with fluid management technology for multiple clinical settings	-	Exigent Capital Group, Bantam Group & 1 others	32/100
5th	Sonogenix Belmont (United States), Unfunded	Developer of non-invasive device for acute and chronic kidney disease	-	-	24/100
6th	Renamed Bio 1995, Waltham (United States), Deadpooled	Developer of renal bio-replacement therapy for compromised kidney function treatment	$40M	-	24/100
7th	CardioRenal Systems Milford (United States), Funding Raised	Manufacturer of medical devices for fluid management and kidney protection	-	Kidron Capital	20/100
8th	Lowell Therapeutics 2018, Lowell (United States), Acqui-Hired	Developer of anticoagulant for the treatment of acute kidney diseases	$1M	Kyto Technology & Life Science	19/100
9th	3ive Labs 2018, Roswell (United States), Unfunded	Developer of devices to restore kidney function	-	-	19/100
10th	EndoVentions 2019, San Rafael (United States), Deadpooled	Developer of devices for treating kidney stones	-	-	14/100